ACTRN12623000882628进行中（未招募）Unknown
Effect of Management of Urinary Tract Infections in Women aged 18-65 years by Community Pharmacists on Self-reported 7-day symptom free rate: PATH-UTI
适应症
试验速览
- 阶段
- Unknown
- 状态
- 进行中（未招募）
- 入组人数
- 18,143
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 分配方式
- Non-randomised trial
- 主要目的
- Treatment
- 盲法
- Open (masking not used)
入排标准
- 年龄范围
- 18 Years 至 65 Years（—）
- 性别
- Female
入选标准
- •Pharmacies and pharmacists recruited must meet the eligibility criteria (defined below) to participate in the study, reflecting the criteria set by the Authority under Section 10 Poisons and Therapeutic Good Act 1966 Clauses 170 and 171 of the Poisons and Therapeutic Goods Regulation 2208.
- •Community pharmacies
- •A community pharmacy in NSW or ACT must have a service room, consulting room, or area consistent with the following:
- •An ‘approved pharmacy’ means a pharmacy or class of pharmacies, approved in writing by the Chief Health Officer, which has a service room, consulting room, or area consistent with the following:
- •o the room or area is not to be used as a dispensary, storeroom, staff room or retail area,
- •o fully enclosed and provides adequate privacy (a divider or curtain in a dispensary, storeroom, staff room or retail area is not acceptable),
- •o has adequate lighting,
- •o is maintained at a comfortable ambient temperature,
- •o has a hand sanitisation facility,
- •o has ready access to a hand washing facility, and
- •o has sufficient floor area, clear of equipment and furniture, to accommodate the person receiving the consultation and an accompanying person, and to allow the pharmacist adequate space to manoeuvre.”
- •Pharmacies must have access to MedAdvisor to complete clinical record keeping for the purposes of the clinical trial assessment.
- •Pharmacists
- •The eligibility criteria for an approved pharmacist to participate in the study, which includes that the pharmacist must be:
- •employed or engaged in an ‘approved pharmacy’ who has successfully completed the following training:
- •Australasian College of Pharmacy Uncomplicated Cystitis Treatment – Pharmacist Training; or
- •Pharmaceutical Society of Australia Managing uncomplicated cystitis; and
- •A series of study training module(s) that have been approved by the Chief Health Officer for the purposes of the clinical trial.”
- •A pharmacist is eligible to participate if they hold general registration as a pharmacist with the Australian Health Practitioner Regulation Agency (AHPRA). Pharmacists with provisional registration (intern pharmacists) and pharmacists with conditions on their registration are not eligible to participate in the trial.
- •The pharmacy must have at least one eligible pharmacist who is willing to provide their voluntary consent to participate, for the pharmacy to be eligible, and that there is always a pharmacist available to deliver the service during all opening hours of the pharmacy.
- •Eligible patients will be females aged between 18 years and 65 years presenting to community pharmacies in NSW, and 5 pharmacies in the ACT, with symptoms associated with an uncomplicated urinary tract infection.
排除标准
- •Individuals who are not female and/or aged <18 years or >65 years.
研究者
相似试验
尚未招募
不适用
urinary tract infection due to catheterizatioCTRI/2019/07/020137Government medical college Bhavnagar
招募中
不适用
Diagnosis and treatment of urinary tract infections in Dutch andGerman primary care settings and their influence on the prevalenceof antibiotic-resistant bacteriancomplicated Urinary Tract InfectionDRKS00030888Carl von Ossietzky Universität Oldenburg250
尚未招募
不适用
Recurrent Urinary tract infection (rUTI)CTRI/2022/09/045671PG Dept of Moalejat General Medicine
招募中
4 期
Gag Therapy for Recurrent urine tract infection Assessing Comparability to International Nitrofurantoin Gold standard study.Urinary tract infections10046590NL-OMON54106Radboud Universitair Medisch Centrum100
进行中（未招募）
3 期
Comparison of 7 days versus 14 days duration of antibiotic therapy for the treatment of infections of the kidney and urinary tractCTRI/2017/05/008684christian medical college research grant